Related Experiment Videos

In vivo modulation of small bowel motility by morphine and D-Ala2 D-Leu5 enkephalin

Life Sciences
|November 15, 1982
PubMed

Insights

Morphine and D-Ala2 D-Leu5 enkephalin (DADLE) affect intestinal motility in dogs. Regular spike activity is a mu receptor effect, while DADLE-induced quiescence may involve delta receptors, suggesting peripheral action for morphine.

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Neuroscience

Background:

  • Opioid receptors play a crucial role in regulating gastrointestinal motility.
  • Understanding the specific receptor interactions of different opioids is essential for therapeutic applications.

Purpose of the Study:

  • To investigate the effects of morphine and D-Ala2 D-Leu5 enkephalin (DADLE) on canine intestinal motility.
  • To differentiate the receptor mechanisms underlying opioid-induced changes in intestinal activity.

Main Methods:

  • Utilized chronic electrode implantation in conscious dogs to monitor intestinal electrical activity.
  • Administered morphine and DADLE, followed by assessments with opioid antagonists Mr2266, naloxone, and nalorphine methiodide.

Main Results:

  • Both morphine and DADLE induced regular spike activity, disrupting normal motility patterns.
  • DADLE also induced a quiescent state, which was not antagonized by naloxone.
  • Opioid antagonists Mr2266 and naloxone blocked the regular spike activity response to both drugs.

Conclusions:

  • Regular spike activity induced by morphine and DADLE is mediated by mu-opioid receptors.
  • DADLE-induced quiescence may be mediated by delta-opioid receptors, indicating distinct receptor pathways.
  • Morphine's effects on intestinal motility appear to involve peripheral receptor sites.

Related Concept Videos